Cargando…
HIV-2 Infection: Where Are We Today?
CONTEXT: The choice of antiretroviral therapy for HIV-2 differs from that for HIV-1, underscoring the importance of differentiating between the two. AIMS: The current study was planned to find out the prevalence of HIV-2 infection at our center and to find out the utility of the current diagnostic a...
Autores principales: | Ingole, Nayana A., Sarkate, Purva P., Paranjpe, Supriya M., Shinde, Sameer D., Lall, Sujata S., Mehta, Preeti R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766332/ https://www.ncbi.nlm.nih.gov/pubmed/24049365 http://dx.doi.org/10.4103/0974-777X.116872 |
Ejemplares similares
-
Monitoring HIV Epidemic in Pregnant Women: Are the Current Measures Enough?
por: Sarkate, Purva, et al.
Publicado: (2015) -
Ocular tuberculosis: Where are we today?
por: Testi, Ilaria, et al.
Publicado: (2020) -
Leishmaniasis Vaccine: Where are We Today?
por: Kedzierski, Lukasz
Publicado: (2010) -
Pathology of thymoma—where are we today?
por: Soomro, Irshad Nabi
Publicado: (2020) -
Refractive surgery: Where are we today?
por: Sachdev, Mahipal S
Publicado: (2020)